Associate, Pureos Bioventures
At Pureos, Ximing is active in deal flow generation, investment due diligence, investment and exit transactions as well as fundraising support. In addition to Tridek-One, Ximing is currently BoD observer at Araris Biotech and Engimmune Therapeutics. He obtained his PhD at the European Molecular Biology Laboratory and holds an MSc. in Biology at ETH Zurich.